Sanofi SA (NAS:SNY)
$ 48.69 0.6274 (1.31%) Market Cap: 121.69 Bil Enterprise Value: 132.17 Bil PE Ratio: 20.85 PB Ratio: 1.53 GF Score: 84/100

Sanofi SA at Citi BioPharma Conference (Virtual) Transcript

Sep 10, 2021 / 01:45PM GMT
Release Date Price: $48.32 (-1.51%)
Peter Verdult
Citigroup Inc., Research Division - MD

So welcome again. Good morning or good afternoon, wherever you're coming from. It's Pete here from the Citi Pharma team. I'm delighted to be introducing Frank Nestle, who is the CSO at Sanofi and Head of Research. We also have with us the IR team.

For those who have been on the conference, it's now day 3, 3 or 4. I'm sure you're hearing me say this, but I will, as always, I'm here to moderate, not monopolize. (Operator Instructions) I will make sure there's questions that I'll put it to Frank. This is going to be pure Q&A rather than prepared slides or commentary because there's a lot to go through. So maybe Frank, I'm kicking off -- sorry to interrupt you there.

Questions & Answers

Peter Verdult
Citigroup Inc., Research Division - MD

So maybe just to kick off, before we get into discussing recent news flow or specific assets, maybe you could just set the scene because we're coming up to a 2-year anniversary of the CMD, where the management team laid out the sort of new vision for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot